Back in 1993, at age 37, Audrey Bahrick, Ph.D., then a psychologist at the University of Iowa, hit an emotional rough patch and started taking Prozac, one of several selective serotonin uptake inhibitors (SSRIs), the most widely prescribed class of antidepressants. As soon as she started taking it, like more than half of SSRI users, Bahrick began experiencing sexual side effects, including stifled sensation.
After two years on Prozac, Bahrick stopped taking it, but her sexuality did not return to normal. Her sex problems persisted. She had what is now increasingly called post-SSRI sexual dysfunction (PSSD). Recognition Took Years.
She wrote an article that was published in a newsletter of the American Psychological Association. She wrote: 'I believe we have barely begun to appreciate the pervasiveness and complexity of these medications' impact on sexuality.'
Collection
[
|
...
]